Caxton Associates (New York)’s Patterson-UTI PTEN Stock Holding History

Caxton Associates (New York)’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$236K	Buy	+28,577	New	+$229K	0.01%	432
2023 Q1	–	Sell	-32,040	Closed	-$540K	–	608
2022 Q4	$540K	Buy	+32,040	New	+$529K	0.04%	224
2019 Q4	–	Sell	-32,448	Closed	-$277K	–	520
2019 Q3	$277K	Buy	+32,448	New	+$318K	0.06%	272
2017 Q4	–	Sell	-544,813	Closed	-$11.4M	–	495
2017 Q3	$11.4M	Sell	544,813 -105,722	-16%	-$1.95M	0.41%	62
2017 Q2	$13.1M	Buy	+650,535	New	+$14.2M	0.51%	47
2017 Q1	–	Sell	-100,000	Closed	-$2.69M	–	434
2016 Q4	$2.69M	Buy	100,000 +50,000	+100%	+$1.23M	0.12%	134
2016 Q3	$1.12M	Sell	50,000 -50,000	-50%	-$1M	0.04%	171
2016 Q2	$2.13M	Buy	+100,000	New	+$1.88M	0.06%	140

Other funds holding PTEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Caxton Associates (New York)'s PTEN Position: Q4 2024 in Review

Caxton Associates (New York) opened a new position in Patterson-UTI (PTEN) in Q4 2024: 28,577 shares worth $236K. The stake represents 0.01% of the portfolio and ranks #432 among its holdings. This is a return to the name: Caxton Associates (New York) previously reported a position in PTEN as recently as Q4 2022.

Caxton Associates (New York) first reported a position in PTEN in Q2 2016 and has held it in 8 quarters since. The position peaked at $13.1M in Q2 2017. 365 funds tracked by Wall St. Rank hold PTEN as of Q4 2024.

Caxton Associates (New York) held 28,577 shares of Patterson-UTI worth $236K as of Q4 2024.
Patterson-UTI was a new Caxton Associates (New York) position in Q4 2024.
Patterson-UTI made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #432 holding.
Caxton Associates (New York) first reported a position in Patterson-UTI in Q2 2016 and has held it in 8 quarters since.
Caxton Associates (New York)'s Patterson-UTI position peaked at $13.1M in Q2 2017.
365 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.